Biotech and Pharma
搜索文档
Protalix, Chiesi reaffirm commitment to Fabry disease patients after EMA panel setback
Proactiveinvestors NA· 2025-10-17 20:26
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Algernon Health completes rebrand to support Alzheimer's diagnostic strategy
Proactiveinvestors NA· 2025-10-15 20:46
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Johnson & Johnson reports Q3 beat, plans orthopaedics spin-off
Proactiveinvestors NA· 2025-10-14 21:54
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Novo Nordisk acquires Akero Therapeutics and its promising liver therapy for up to $5.2B
Proactiveinvestors NA· 2025-10-09 20:54
文章核心观点 - 内容发布商Proactive是一家为全球投资受众提供快速、易获取、信息丰富且可操作的商业及金融新闻内容的机构 [2] - 公司专注于中小型市值公司市场 同时也覆盖蓝筹股、大宗商品及更广泛的投资领域 [3] - 所有发布的内容均由经验丰富且合格的人类新闻记者团队独立制作 并经过人类编辑和撰写 [2][5] 公司业务与覆盖范围 - 新闻团队遍布全球主要金融和投资中心 包括伦敦、纽约、多伦多、温哥华、悉尼和珀斯 [2] - 市场覆盖范围广泛 包括但不限于生物技术、制药、采矿与自然资源、电池金属、石油和天然气、加密货币以及新兴的数字和电动汽车技术 [3] 内容制作与技术应用 - 公司采用前瞻性技术 人类内容创作者拥有数十年宝贵的专业知识和经验 [4] - 团队会使用技术来协助和增强工作流程 包括自动化和软件工具 例如生成式人工智能 [4][5] - 尽管使用技术工具 但所有发布的内容均符合内容制作和搜索引擎优化的最佳实践 并确保由人类主导 [5]
Bubble, or are we at the start of an AI capex super-cycle?
Proactiveinvestors NA· 2025-10-04 03:33
About this content About Ian Lyall Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually. Prior to Proactive, Ian helped lead the business outpu ...
Regeneron Pharmaceuticals catalysts could drive stock higher: analysts
Proactiveinvestors NA· 2025-10-03 22:11
About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...
Hang Seng Index Reaches 4-Year Peak
FinanceFeeds· 2025-10-02 17:34
恒生指数表现 - 香港恒生指数攀升至27300点以上 为2021年夏季以来首次达到该水平 [1] - 自9月1日以来 恒生指数涨幅超过7% [2] 个股驱动因素 - 中国电动汽车制造商蔚来汽车宣布汽车交付量同比增长641% 股价上涨约5% [1] - 歌礼制药宣布股份回购计划后 股价飙升128% [2] - 摩根大通将阿里巴巴目标价上调超过40% 理由为人工智能领域强劲发展和稳健的用户参与度 阿里巴巴股价上涨4% [2] 技术分析 - 价格在26000点关键心理位附近获得支撑 空头尝试下破失败后 多头占据优势并推动指数大幅上行 [5][6] - 市场恢复上行趋势 果断突破红色修正性牛旗形态 并强势突破27000点附近的9月高点 长蜡烛图显示供需失衡有利于买方 [6][7] - 价格目前在蓝色上升通道的上半部交易 显示强劲的买入兴趣 [7] - RSI指标已进入超买区域 初步乐观情绪消退后可能出现获利了结 引发向27000点或下方橙色趋势线的回调 [8]
Tiziana Life Sciences to showcase drug candidate at Saudi innovation forum
Proactiveinvestors NA· 2025-09-30 20:47
About this content About Ian Lyall Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually. Prior to Proactive, Ian helped lead the business outpu ...
MoonLake Immunotherapeutics analysts slash target price as trial results disappoint
Proactiveinvestors NA· 2025-09-30 03:46
About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...
374Water sees ‘significant' revenue potential from WDS, actively bidding on multi million dollars in contracts
Proactiveinvestors NA· 2025-09-29 21:52
公司概况 - 公司为全球投资受众提供快速、易获取、信息丰富且可操作的商业和金融新闻内容 [1] - 公司内容由经验丰富且合格的新闻记者团队独立制作 [1] - 公司新闻团队覆盖全球主要金融和投资中心,在伦敦、纽约、多伦多、温哥华、悉尼和珀斯设有办事处和演播室 [2] 内容专长 - 公司在中小型市值市场方面是专家,同时也向投资者社区更新蓝筹股公司、大宗商品和更广泛的投资故事 [2] - 团队提供跨市场的新闻和独特见解,包括但不限于生物技术和制药、采矿和自然资源、电池金属、石油和天然气、加密货币以及新兴数字和电动汽车技术 [3] 技术应用 - 公司一直是前瞻性且热情的技术采用者 [4] - 人类内容创作者拥有数十年宝贵的专业知识和经验,团队也使用技术来协助和增强工作流程 [4] - 公司会偶尔使用自动化和软件工具,包括生成式人工智能,但所有发布的内容均由人类编辑和撰写 [5]